Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02748148 · ClinicalTrials.gov registry record · NA
Implementation Study of Enhanced Medication Therapy Management in Primary Care Practice
A NA study of Medication Therapy Management and Pharmacogenomics, sponsored by Tabula Rasa HealthCare.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT02748148: Completed NA study of Medication Therapy Management and Pharmacogenomics, sponsored by Tabula Rasa HealthCare.
NCT02748148 is a NA study of Medication Therapy Management and Pharmacogenomics that has completed, run by Tabula Rasa HealthCare. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02748148, a NA study of Medication Therapy Management and Pharmacogenomics, has completed, sponsored by Tabula Rasa HealthCare.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify challenges and successes associated with implementing an enhanced medication therapy management service in primary care practice.
Primary Outcome
Implementation
Conditions Studied
Interventions
- OTHER Medication therapy management
Study Locations (1)
New Jersey
- Elmwood Family Physicians - Marlton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-04 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT02748148 record still lists
NCT02748148 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Medication Therapy Management appearing as the primary indexed condition, and to 1 intervention - of which Medication therapy management is the first listed.
NCT02748148 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT02748148 about?
NCT02748148 is a clinical study titled "Implementation Study of Enhanced Medication Therapy Management in Primary Care Practice". The purpose of this study is to identify challenges and successes associated with implementing an enhanced medication therapy management service in primary care practice.
What is the current status of trial NCT02748148?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-04. Estimated completion is 2016-09.
What conditions does trial NCT02748148 study?
This clinical trial studies the following conditions: Medication Therapy Management, Pharmacogenomics.
What interventions are being tested in trial NCT02748148?
The interventions under investigation include: Medication therapy management (OTHER).
Who is sponsoring clinical trial NCT02748148?
This trial is sponsored by Tabula Rasa HealthCare, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02748148 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Medication Therapy Management
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02748148's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia